Always consult a medical doctor or patient care specialist before using zolmitriptan nasal spray.
Indications and Usage
Zolmitriptan is in a class of medications called selective serotonin receptor agonists. It is indicated for the acute treatment of migraine with or without aura in adults.
It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine.
Do not take zolmitriptan nasal spray if:
- You smoke or if you are overweight;
- You have heart disease or had an heart attack;
- You liver or kidney disease;
- You have Raynaud’s disease (problems with blood flow to the fingers, toes, ears, and nose), or ischemic bowel disease (bloody diarrhea and stomach pain caused by decreased blood flow to the intestines).
Consult with your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you got pregnant while using zolmitriptan nasal spray, call your doctor.
You should know that zolmitriptan nasal spray may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
Administration and Dosage
Refer to your doctor or pharmacist for guidelines on dosage. The recommended dose to treat allergic reactions of the nose is 1-2 spray in each nostril three times a day. It is usually used every 8-10 hours as needed, but not more often than twice in a 24-hour period.
Consult with your doctor about medications you are taking or existing medical conditions you have before your treatment with zolmitriptan nasal spray.
It may interact with acetaminophen antidepressants such as amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine nortriptyline, protriptyline and trimipramin; aspirin and other non-steroidal anti-inflammatory medications (NSAIDs) such as ibuprofen and naproxen; cimetidine; oral contraceptives and selective serotonin/norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine duloxetine, sibutramine and venlafaxine.
Symptoms of overdose include drowsiness or sleepiness. These symptoms have to be reported to the medical health professional.
No adverse reactions have been reported.